Mednax reportedly fielding interest from private equity firms

Mednax, the Terrace Sunrise, Fla.-based healthcare provider, is “fielding acquisition interest” from numerous private equity firms, according to a story reported Friday by Reuters. Mednax acquired teleradiology giant vRad in 2015 for $500 million.

According to the report, which says its information comes from anonymous sources close to Mednax, there is no certainty that a deal will occur and the company “has not yet started the process of selling itself.”

Earlier this month, Paul Singer’s hedge fund, Elliott Management, bought seven percent of Mednax and is said to be asking the board of directors to consider selling the company.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup